CXCL17 and neoplasm: Since it is well known that tumor-bearing conditions significantly increased the population number of CD11b+Gr-1+ myeloid-derived cells in the spleen of immune-competent mice [6], we further examined whether CXCL17 expression could increase the population number of CD11b+Gr-1+ myeloid-derived cells.